|
Basic Characteristics of Mutations
|
|
Mutation Site
|
R32G |
|
Mutation Site Sentence
|
Table 4 |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
X |
|
Standardized Encoding Gene
|
X
|
|
Genotype/Subtype
|
A |
|
Viral Reference
|
KC875257.1
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Occult HBV Infection
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
India |
|
Literature Information
|
|
PMID
|
31601912
|
|
Title
|
Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection
|
|
Author
|
Sinha M,Sundar K,Premalata CS,Asati V,Murali A,Bajpai AK,Davuluri S,Acharya KK,Lakshmaiah KC,Babu K G,Jacob LA,Nandan D,Velayutham D,Datta S,Jayshree RS
|
|
Journal
|
Scientific reports
|
|
Journal Info
|
2019 Oct 10;9(1):14516
|
|
Abstract
|
Non Hodgkin lymphoma, predominantly Diffuse Large B-cell Lymphoma (DLBCL) has been reported to have a significant association with Hepatitis B virus (HBV). We investigated the presence of different gene segments of HBV in plasma, B-cells and tumor tissues from DLBCL patients and explored the genetic variability of HBV within and across different compartments in a host using Next Generation Sequencing. Despite all 40 patients being HBV seronegative, 68% showed evidence of occult HBV. Sequencing of these gene segments revealed inter-compartment viral variants in 26% of them, each with at least one non-synonymous mutation. Between compartments, core gene variants revealed Arg94Leu, Glu86Arg and Ser41Thr while X gene variants revealed Phe73Val, Ala44Val, Ser146Ala and Ser147Pro. In tumor compartments per se, several mis-sense mutations were detected, notably the classic T1762A/A1764G mutation in the basal core promoter. In addition, a virus surface antigen mis-sense mutation resulting in M125T was detected in all the samples and could account for surface antigen negativity and occult HBV status. It would be interesting to further explore if a temporal accumulation of viral variants within a favored niche, like patients' lymphocytes, could bestow survival advantage to the virus, and if certain pro-oncogenic HBV variants could drive lymphomagenesis in DLBCL.
|
|
Sequence Data
|
-
|
|
|